Por: The Boston Globe Business November 09, 2022
A Watertown biotech company has taken a small step forward in its ambitions to give Pfizer’s COVID pill Paxlovid some competition. Enanta Pharmaceuticals told the Globe it has begun an intermediate stage clinical trial of its experimental COVID therapy this week.Enanta hopes its once-daily pill will be safer to prescribe, easier to take, and potentially more effective than Paxlovid, which is set to earn the pharma giant $22 billion this year.... + full article
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
CNBC USA Health November 01, 2022
In this articleVials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido Reuters on Tuesday raised its 2022 earnings guidance after... + más
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
The Boston Globe USA Sports November 01, 2022
Two months of high-level regular-season field hockey have come and gone, and now begins a new season: the MIAA statewide tournament.Program participation in the postseason remains large in the wake of the MIAA’s realignment to four divisions in advance of the 2021 tournament:... + más
MIAA’s tournament management committee declines proposal to adjust restrictions on out-of-season coaching | The Boston Globe
Justin Trudeau Says Hockey Canada Response to Assault Allegations 'Boggles the Mind' | Bleacher Report
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Boston Globe USA Business September 28, 2022
The series looks at the past, present, and future of neighborhoods in Greater Boston.SUPPORTED BY WATERTOWN ― There are plenty of reasons to visit Watertown Square. Among them: the gorgeous library, the weekly farmers market, and the Armenian Museum. But there’s something... + más
Not far from Kendall Square, Watertown emerges as a biotech hub | The Boston Globe
Watertown has been a city for decades. Now, it’s acting like one. | The Boston Globe
The series looks at the past, present, and future of neighborhoods in Greater Boston.SUPPORTED BY WATERTOWN — Armon Sharei moved to Watertown before it was cool.Five years ago, the CEO of SQZ Biotech, a fast-growing cell therapy startup that Sharei helped spin out of MIT, was... + más
In a work-from-anywhere world, how will Kendall Square adapt for the future? | The Boston Globe
WATERTOWN – There’s a spot on Coolidge Avenue in Watertown’s East End where you can see what this community has long been, and what it is rapidly becoming.An asphalt plant sits across the street from a UPS depot, around the corner from a wholesale tile and countertop... + más
Watertown transformed Arsenal Yards. What about its downtown? | The Boston Globe
About iurex | Privacy Policy | Disclaimer |